Search Results - "Marsh, C. L."

Refine Results
  1. 1
  2. 2

    Challenges to Research and Innovation to Optimize Deceased Donor Organ Quality and Quantity by Abt, P. L., Marsh, C. L., Dunn, T. B., Hewitt, W. R., Rodrigue, J. R., Ham, J. M., Feng, S.

    Published in American journal of transplantation (01-06-2013)
    “…Solid organ transplantation is encumbered by an increasing number of waitlisted patients unrequited by the current organ supply. Preclinical models suggest…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Realising resource efficiency in the management of healthcare waste from the Cornwall National Health Service (NHS) in the UK by Tudor, T.L., Marsh, C.L., Butler, S., Van Horn, J.A., Jenkin, L.E.T.

    Published in Waste management (Elmsford) (2008)
    “…The quantities of waste generated by the healthcare sector in the United Kingdom (UK) have been shown to be amongst the highest in Europe. Based on a case…”
    Get full text
    Journal Article
  5. 5

    Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and wistar rat islets by PATY, B. W, HARMON, J. S, MARSH, C. L, ROBERTSON, R. P

    Published in Transplantation (15-02-2002)
    “…Until recently, islet allotransplantation for type 1 diabetic patients has been largely unsuccessful. Previous pharmacologic studies of single drugs have…”
    Get full text
    Journal Article
  6. 6

    The Current State of Liver Transplantation in the United States: Perspective From American Society of Transplant Surgeons (ASTS) Scientific Studies Committee and Endorsed by ASTS Council by Fayek, S A, Quintini, C, Chavin, K D, Marsh, C L

    Published in American journal of transplantation (01-11-2016)
    “…This article is a review of the salient points and a future prospective based on the 2014 Organ Procurement and Transplantation Network (OPTN)/Scientific…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Kidney Exchange to Overcome Financial Barriers to Kidney Transplantation by Rees, M. A., Dunn, T. B., Kuhr, C. S., Marsh, C. L., Rogers, J., Rees, S. E., Cicero, A., Reece, L. J., Roth, A. E., Ekwenna, O., Fumo, D. E., Krawiec, K. D., Kopke, J. E., Jain, S., Tan, M., Paloyo, S. R.

    Published in American journal of transplantation (01-03-2017)
    “…Organ shortage is the major limitation to kidney transplantation in the developed world. Conversely, millions of patients in the developing world with…”
    Get full text
    Journal Article
  9. 9

    Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients by Thummel, K E, Shen, D D, Podoll, T D, Kunze, K L, Trager, W F, Hartwell, P S, Raisys, V A, Marsh, C L, McVicar, J P, Barr, D M

    “…The clearance of midazolam (MDZ) in humans is principally due to metabolic biotransformation catalyzed by CYP3A isoforms. A study was conducted in patients who…”
    Get more information
    Journal Article
  10. 10

    Long-term cognitive and psychiatric outcomes of acute respiratory distress syndrome managed with Extracorporeal Membrane Oxygenation by Marsh, L.C., Leach, R.M., Blane, J., Daly, K., Barrett, N.A., Slack, A., Kopelman, M.D.

    Published in Respiratory medicine (01-07-2021)
    “…Cognitive dysfunction is often reported in patients who have experienced acute respiratory distress syndrome (ARDS). Extra Corporeal Membrane Oxygenation…”
    Get full text
    Journal Article
  11. 11

    First-pass metabolism of midazolam by the human intestine by Paine, M F, Shen, D D, Kunze, K L, Perkins, J D, Marsh, C L, McVicar, J P, Barr, D M, Gillies, B S, Thummel, K E

    Published in Clinical pharmacology and therapeutics (01-07-1996)
    “…The in vivo intestinal metabolism of the CYP3A probe midazolam to its principal metabolite, 1'-hydroxymidazolam, was investigated during surgery in 10 liver…”
    Get more information
    Journal Article
  12. 12

    Ureteral Complications in Renal Transplantation: A Comparison of the Lich-Gregoir Versus the Taguchi Technique by Lee, R.S, Bakthavatsalam, R, Marsh, C.L, Kuhr, C.S

    Published in Transplantation proceedings (01-06-2007)
    “…Abstract Objective Modifications of the Lich-Gregoir extravesical ureteroneocystostomy have become the standard technique for management of the ureter during…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantation by Thummel, K E, Shen, D D, Podoll, T D, Kunze, K L, Trager, W F, Bacchi, C E, Marsh, C L, McVicar, J P, Barr, D M, Perkins, J D

    “…Immunosuppression therapy with cyclosporine is often hampered by significant interindividual variability in the metabolic clearance of the drug. It has been…”
    Get more information
    Journal Article
  15. 15
  16. 16

    The Current State of Liver Transplantation in the United States by Fayek, S. A., Quintini, C., Chavin, K. D., Marsh, C. L.

    Published in American journal of transplantation (01-11-2016)
    “…This article is a review of the salient points and a future prospective based on the 2014 Organ Procurement and Transplantation Network (OPTN)/Scientific…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Investigator Assessment of the Utility of the TruGraf Molecular Diagnostic Test in Clinical Practice by First, M.R., Peddi, V.R., Mannon, R., Knight, R., Marsh, C.L., Kurian, S.M., Rice, J.C., Maluf, D., Mandelbrot, D., Patel, A., David, J., Schieve, C., Lee, D., Lewis, P., Friedewald, J.J., Abecassis, M.M., Rose, S.

    Published in Transplantation proceedings (01-04-2019)
    “…TruGraf v1 is a well-validated DNA microarray-based test that analyzes blood gene expression profiles as an indicator of immune status in kidney transplant…”
    Get full text
    Journal Article
  19. 19

    Effects of Rifampin on Tacrolimus Pharmacokinetics in Healthy Volunteers by Hebert, Mary F., Fisher, Richard M., Marsh, Christopher L., Dressler, Dawna, Bekersky, Ihor

    Published in Journal of clinical pharmacology (01-01-1999)
    “…Tacrolimus is a marketed immunosuppressant used in liver and kidney transplantation. It is subject to extensive metabolism by CYP3A4 and is a substrate for…”
    Get full text
    Journal Article
  20. 20

    Low Dose Rate Irradiation Facility: initial study on chronic exposures to medaka by Hinton, T.G, Coughlin, D.P, Yi, Yi, Marsh, L.C

    “…Uncertainties associated with the effects from chronic low-level exposures to radiation prompted us to construct a Low Dose Rate Irradiation Facility (LoDIF)…”
    Get full text
    Journal Article Conference Proceeding